Terumo Corporation

Equities

4543

JP3546800008

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-24 am EDT 5-day change 1st Jan Change
2,680 JPY +2.29% Intraday chart for Terumo Corporation +3.22% +15.97%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Penumbra, Inc. : The underdog in healthcare Our Logo
Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation CI
Jefferies Adjusts Terumo’s Price Target to 6,700 Yen From 5,300 Yen, Keeps at Buy MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023. CI
Terumo Corporation's Equity Buyback announced on August 9, 2023, has closed with 3,380,000 shares, representing 0.45% for ¥11,097.09 million. CI
Terumo Repurchases 521 Million Yen Shares in February MT
Terumo Corp to Undertake One-to-Two Share Split MT
Terumo's Attributable Profit Climbs 13.8% in Fiscal Nine Months MT
Transcript : Terumo Corporation, Q3 2024 Earnings Call, Feb 07, 2024
Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023 CI
Terumo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Terumo Reacquires Over 500,000 Shares in January MT
Terumo Repurchases Shares MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023. CI
Jefferies Adjusts Terumo's Price Target to 5,300 Yen From 4,500 Yen, Keeps at Buy MT
Hikaru Samejima to Assume Position as President and CEO of Terumo Corp. in April 2024 MT
Shinjiro Sato to Leave as CEO of Terumo Corporation on April 1, 2024 CI
Terumo Corporation Announces Management Changes, Effective from April 1, 2024 CI
Terumo Repurchases 629,300 Shares in November MT
Transcript : Terumo Corporation, Q2 2024 Earnings Call, Nov 15, 2023
Japanese Shares Continue Winning Streak on Wednesday Amid Rising Hopes on US Rate-Hike Pause MT
Japan's Nikkei jumps 2% on strong earnings, dovish Fed bets RE
Terumo's Fiscal H1 Attributable Profit Climbs on Strong Infusion, Catheter Product Sales; Shares Surge 10% MT
Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Chart Terumo Corporation
More charts
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows: - cardiac surgery devices (53.5%); - medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.; - sanguine transfusion equipments (17.9%). Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,620 JPY
Average target price
2,951 JPY
Spread / Average Target
+12.63%
Consensus
  1. Stock Market
  2. Equities
  3. 4543 Stock
  4. News Terumo Corporation
  5. Terumo Issues Restricted Stocks Worth $37.5 Million as Remuneration